According to a new market report published by Transparency Market
Research, the global diabetic foot ulcers treatment market was valued at US$ 5 Bn in
2018 and is estimated to reach a market value of ~US$ 9.6 Bn by 2027, growing
at a CAGR of 7.5% from 2019 to 2027. Diabetic
foot ulcers are a major complication arising out of diabetes mellitus. Various
factors are responsible for this type of chronic wound, such as peripheral
neuropathy, and peripheral artery diseases. Chronic wounds have created a
significant socioeconomic impact. Chronic wounds generally take longer time to
heal and require advanced wound care therapies. Diabetic ulcers are becoming
more common due to increased incidence of both type I and maturity-onset
diabetes in the developed economies across the world. Thus, increase in
prevalence of diabetic foot ulcer is expected to drive the diabetic foot ulcers
treatment market in the next few years.
Read
Report Overview -
https://www.transparencymarketresearch.com/diabetic-foot-ulcers-treatment-market.html
The global diabetic foot ulcers treatment market was valued at US$
5.0 Bn in 2018 and is anticipated to reach US$
9.6 Bn by 2027, expanding at a CAGR of 7.5% from 2019 to 2027. North
America, Europe, and Asia Pacific were major markets for diabetic foot ulcers
treatment in 2018. Global diabetic foot ulcers treatment
market in Asia Pacific is projected to expand at a high CAGR of 8.0% during
the forecast period.
Rise in Prevalence of Chronic Disease to Drive
Market
High growth rate of the diabetic foot ulcers treatment market during the
forecast period can be attributed to rise in prevalence of chronic diseases
such as diabetes, cancer, HIV, and other diseases leading to increased risk of
diabetic foot ulcers among the diabetic population; and longer hospital stays
due to treatment of these diseases resulting in risk of hospital-acquired
pressure ulcers and medical devices-acquired pressure ulcers. A constant
increase in geriatric population among developed and developing countries has
been observed, along with rise in obesity and peripheral artery diseases, which
leads to decreased mobility and increased risk of acquiring chronic ulcers
Wound Care Dressings to be Preferred Treatment Type
In terms of treatment type, the diabetic foot ulcers treatment market
has been segmented into wound care dressings, wound care devices, active
therapies, and others. The wound care dressings segment is anticipated to hold
major share of the market during the forecast period. Increase in incidence of
peripheral vascular as well sugar related diseases, and other chronic diseases
leading to rising risk of hospital acquired pressure ulcers is expected to
drive the segment during the forecast period
Grade 1 Ulcers to Dominate Global Market
In term of grade, the diabetic foot ulcers treatment market has been
segmented into grade 1, grade 2, grade 3, grade 4, and grade 5. The grade 1
segment is expected to dominate the market during the forecast period.
Rise in Prevalence of Neuropathic Ulcers to Fuel
Market Growth
In terms of type of ulcer, the diabetic foot ulcers treatment market has
been segmented into neuropathic ulcers and ischemic ulcers. The neuropathic
ulcers segment is expected to dominate the market from 2019 to 2027.
Request COVID Analysis on Diabetic Foot Ulcers Treatment Market
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=75725
Hospital Inpatient Settings to be Key End User
In terms of end user, the diabetic foot ulcers treatment market has been
categorized into hospital inpatient settings, hospital outpatient settings,
community health centers, and home healthcare. In terms of end user, the
hospital inpatient settings segment is expected to drive the market. Reasons
for growth of the segment include the demand for acute care for the treatment
of chronic wounds and rise in incidence of diabetic foot ulcers and pressure
ulcers around the world. However, lack of hospital inpatient facilities and
availability of limited resources have led to emergence of community health
centers and home healthcare facilities for wound care. This is expected to drive
community health centers and home healthcare segments during the forecast
period.
Buy Diabetic Foot Ulcers Treatment Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=75725<ype=S
Growth Strategies of Key Players: Diabetic
Foot Ulcers Treatment Market
Major players having presence in the global diabetic foot ulcers
treatment market include 3M Healthcare, Smith & Nephew Plc.,
Acelity L.P. Inc., ConvaTec, Inc., Molnlycke Health Care AB, Coloplast A/S,
Medtronic Plc, B. Braun Melsungen AG, Organogenesis, Inc., Medline Industries,
Inc., and BSN Medical GMBH. These companies engage in research & development
activities to develop novel products in order to expand product offerings and
customer base
Global Diabetic Foot Ulcers Treatment Market:
Segmentation
Diabetic Foot Ulcers Treatment Market, by Treatment
Type
·
o
o
o
o
o
o
·
o
o
o
·
o
o
o
·
o
o
o
Diabetic Foot Ulcers Treatment Market, by Grade
·
·
·
·
·
Diabetic Foot Ulcers Treatment Market, by Type of Ulcer
·
·
Diabetic Foot Ulcers Treatment Market, by End User
·
·
·
·
Diabetic Foot Ulcers Treatment Market, by Region
·
o
o
·
o
o
o
o
o
o
·
o
o
o
o
o
·
o
o
o
·
o
o
o
o
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. We have an experienced team of
analysts, researchers, and consultants who use proprietary data sources and
various tools and techniques to gather and analyze information. Our business
offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector — such as
pharmaceuticals, chemical, energy, food & beverages, semiconductors,
med-devices, consumer goods, and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider scope and
stratified research methodology, our syndicated reports thrive to provide
clients to serve their overall research requirement.
Contact
TMR
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/
